Klaria Pharma (Sweden) Analysis
| KLAR Stock | SEK 0.40 0.02 5.26% |
Klaria Pharma Holding is overvalued with Real Value of 0.38 and Hype Value of 0.4. The main objective of Klaria Pharma stock analysis is to determine its intrinsic value, which is an estimate of what Klaria Pharma Holding is worth, separate from its market price. There are two main types of Klaria Pharma's stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Klaria Pharma's performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Klaria Pharma's stock to identify patterns and trends that may indicate its future price movements.
The Klaria Pharma stock is traded in Sweden on Stockholm Exchange, with the market opening at 09:00:00 and closing at 17:30:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in Sweden. Klaria Pharma is usually not traded on NationalDay, International Workers ' Day, St . John 's Day, All Saints ' Day, Christmas Eve, Christmas Day, Boxing Day, New Year 's Day, Epiphany, Good Friday, Easter Sunday, Easter Monday. Klaria Stock trading window is adjusted to Europe/Stockholm timezone.
Klaria |
Klaria Stock Analysis Notes
The company has price-to-book ratio of 1.42. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Klaria Pharma Holding recorded a loss per share of 1.72. The entity had not issued any dividends in recent years. Klaria Pharma Holding AB develops treatment methods in the therapeutic fields of migraine and pain related to cancer worldwide. Klaria Pharma Holding AB was founded in 2014 and is based in Uppsala, Sweden. Klaria Pharma is traded on Stockholm Stock Exchange in Sweden. To find out more about Klaria Pharma Holding contact the company at 46 84 46 42 99 or learn more at https://www.klaria.com.Klaria Pharma Holding Investment Alerts
| Klaria Pharma had very high historical volatility over the last 90 days | |
| Klaria Pharma has some characteristics of a very speculative penny stock | |
| Klaria Pharma Holding has accumulated 1.02 M in total debt. Klaria Pharma Holding has a current ratio of 0.67, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Klaria Pharma until it has trouble settling it off, either with new capital or with free cash flow. So, Klaria Pharma's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Klaria Pharma Holding sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Klaria to invest in growth at high rates of return. When we think about Klaria Pharma's use of debt, we should always consider it together with cash and equity. | |
| Net Loss for the year was (53.53 M) with profit before overhead, payroll, taxes, and interest of 5.87 M. | |
| Klaria Pharma Holding has accumulated about 25.49 M in cash with (24.8 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.47, which can makes it an attractive takeover target, given it will continue generating positive cash flow. |
Klaria Market Capitalization
The company currently falls under 'Micro-Cap' category with a current market capitalization of 39.49 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Klaria Pharma's market, we take the total number of its shares issued and multiply it by Klaria Pharma's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Technical Drivers
As of the 23rd of November, Klaria Pharma secures the Downside Deviation of 9.09, risk adjusted performance of 0.0157, and Mean Deviation of 5.21. Klaria Pharma Holding technical analysis lets you operate historical price patterns with an objective to determine a pattern that forecasts the direction of the firm's future prices.Klaria Pharma Holding Price Movement Analysis
The output start index for this execution was two with a total number of output elements of fifty-nine. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Klaria Pharma middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Klaria Pharma Holding. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Klaria Pharma Outstanding Bonds
Klaria Pharma issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Klaria Pharma Holding uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Klaria bonds can be classified according to their maturity, which is the date when Klaria Pharma Holding has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| Volcan Compania Minera Corp BondUSP98047AC08 | View | |
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| HSBC Holdings PLC Corp BondUS404280DR76 | View | |
| MPLX LP 4875 Corp BondUS55336VAG59 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| International Game Technology Corp BondUS460599AD57 | View | |
| BNP Paribas FRN Corp BondUSF1R15XK367 | View |
Klaria Pharma Predictive Daily Indicators
Klaria Pharma intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Klaria Pharma stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Klaria Pharma Forecast Models
Klaria Pharma's time-series forecasting models are one of many Klaria Pharma's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Klaria Pharma's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Klaria Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Klaria Pharma prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Klaria shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Klaria Pharma. By using and applying Klaria Stock analysis, traders can create a robust methodology for identifying Klaria entry and exit points for their positions.
Klaria Pharma Holding AB develops treatment methods in the therapeutic fields of migraine and pain related to cancer worldwide. Klaria Pharma Holding AB was founded in 2014 and is based in Uppsala, Sweden. Klaria Pharma is traded on Stockholm Stock Exchange in Sweden.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Klaria Pharma to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Insider Screener Now
Insider ScreenerFind insiders across different sectors to evaluate their impact on performance |
| All Next | Launch Module |
Additional Tools for Klaria Stock Analysis
When running Klaria Pharma's price analysis, check to measure Klaria Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Klaria Pharma is operating at the current time. Most of Klaria Pharma's value examination focuses on studying past and present price action to predict the probability of Klaria Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Klaria Pharma's price. Additionally, you may evaluate how the addition of Klaria Pharma to your portfolios can decrease your overall portfolio volatility.